Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).

scientific article

Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/01.WNL.0000341274.61236.02
P698PubMed publication ID19171827

P50authorGrete AndersenQ54156230
P2093author name stringJ Vissing
C Crone
N Preisler
F Wibrand
T D Jeppesen
F Thøgersen
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectmuscular atrophyQ2844600
P304page(s)317-323
P577publication date2009-01-01
P1433published inNeurologyQ1161692
P1476titleEffect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).
P478volume72

Reverse relations

cites work (P2860)
Q35935094A randomized controlled trial of exercise in spinal and bulbar muscular atrophy
Q35890267Aerobic Training in Patients with Congenital Myopathy
Q38634370Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and Future
Q34622281Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Q38639343Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders.
Q38108541Exercise in neuromuscular disease
Q92863877Exercise therapy for muscle and lower motor neuron diseases
Q90026120High-intensity training in patients with spinal and bulbar muscular atrophy
Q39968447Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice
Q38597312Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease).
Q64082911Muscle contractility in spinobulbar muscular atrophy
Q37899974Neurotoxic effects of androgens in spinal and bulbar muscular atrophy.
Q34637225Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
Q27007098Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy
Q38246221Potential therapeutic targets in polyglutamine-mediated diseases
Q58564785Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial
Q42002252Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative?
Q34499899Spinal and Bulbar Muscular Atrophy.
Q30612908Spinal and bulbar muscular atrophy: pathogenesis and clinical management
Q91813426The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations
Q64085965The effect of two different aerobic training modalities in a child with spinal muscular atrophy type II: a case report
Q33701169Therapeutic approaches to spinal and bulbar muscular atrophy
Q48015086Training improves oxidative capacity, but not function, in spinal muscular atrophy type III.
Q37572139Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy

Search more.